Menopausal stages and overactive bladder symptoms in middle‐aged women: A cross‐sectional study
Objective To examine the prevalence of overactive bladder (OAB) according to menopausal stages in middle‐aged women. Design Cross‐sectional study. Setting Total Healthcare Center in South Korea. Population Middle‐aged Korean women (n=3469, mean age, 49.5 ± 2.9 years). Methods Menopausal stages were...
Gespeichert in:
Veröffentlicht in: | BJOG : an international journal of obstetrics and gynaecology 2024-12, Vol.131 (13), p.1805-1814 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
To examine the prevalence of overactive bladder (OAB) according to menopausal stages in middle‐aged women.
Design
Cross‐sectional study.
Setting
Total Healthcare Center in South Korea.
Population
Middle‐aged Korean women (n=3469, mean age, 49.5 ± 2.9 years).
Methods
Menopausal stages were defined according to the Stages of Reproductive Aging Workshop +10 criteria, and menopausal symptoms were assessed using the Korean version of Menopause‐Specific Quality of Life (MENQOL). Logistic regression models were used to estimate prevalence ratios with 95% confidence intervals for OAB according to menopausal stage and to assess the associations with menopausal symptoms.
Main Outcome Measures
OAB symptoms were evaluated using the Overactive Bladder Symptom Score (OABSS).
Results
The prevalence of OAB increased with menopausal stage; however, the multivariable‐adjusted prevalence ratios for women in menopausal transition and postmenopausal stage were insignificant (ptrend = 0.160) compared to those for premenopausal women. Among individual OAB symptoms, the multivariable‐adjusted prevalence ratios for nocturia increased with menopausal stage in a dose–response manner (ptrend = 0.005 for 1 time/day; ptrend |
---|---|
ISSN: | 1470-0328 1471-0528 1471-0528 |
DOI: | 10.1111/1471-0528.17912 |